Psychiatry and Neurology, Neurology · Miami, FL
NPI
1932341104
Since 2009
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8700 W Flagler St Ste 420
Miami, FL, 33174
Phone (305) 608-0656
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
395 services
Medicare patients, 2024
130
Average age 75
Drug cost, 2024
$493K
5,717 prescriptions
Company payments, 2025
$600
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daisy Borroto Conde was code 99214 (office e&m - established), 197 times for 108 patients. In total Daisy Borroto Conde billed 395 services in 12 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 197 | 108 | $104.10 | $21K |
| 95816 Neurologic | Office | 48 | 48 | $317.98 | $15K |
| 99204 Office E&M - New | Office | 45 | 45 | $138.80 | $6,246 |
| 95957 Neurologic | Office | 44 | 44 | $238.27 | $10K |
| 96116 Behavioral Health Services | Office | 12 | 12 | $75.63 | $908 |
By year: 2022 $103K for 655 services; 2023 $70K for 472 services; 2024 $58K for 395 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daisy Borroto Conde prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 540 prescriptions and refills. In total Daisy Borroto Conde wrote 5,717 Medicare prescriptions that cost $493K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 540 | 870 | 161 | $7,703 |
| Donepezil Hcl Generic | 535 | 834 | 159 | $3,779 |
| Galantamine Hbr Generic | 512 | 773 | 156 | $22K |
| Pregabalin Generic | 353 | 368 | 83 | $10K |
| Gabapentin Generic | 295 | 376 | 113 | $1,661 |
| Folic Acid Generic | 287 | 390 | 104 | $571 |
| Memantine Hcl Generic | 234 | 376 | 79 | $2,371 |
| Levetiracetam Generic | 172 | 279 | 52 | $3,002 |
| Clopidogrel Clopidogrel Bisulfate | 168 | 294 | 59 | $884 |
| Quetiapine Fumarate Generic | 139 | 187 | 30 | $914 |
| Escitalopram Oxalate Generic | 138 | 263 | 62 | $992 |
| Memantine Hcl Er Memantine Hcl | 130 | 205 | 39 | $24K |
| Rytary Carbidopa/Levodopa | 117 | 126 | 28 | $49K |
| Levetiracetam Er Levetiracetam | 97 | 129 | 22 | $2,680 |
| Benztropine Mesylate Generic | 97 | 149 | 32 | $1,057 |
Brand drugs: 375 claims; generic drugs: 5,300 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daisy Borroto Conde $600 ($600 in general payments such as food, travel and fees) from 9 companies. The largest payer was Janssen Biotech, Inc. with $172.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 5 | $172 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $162 |
| Argenx US, Inc. ARGX | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $33.04 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $32.25 |
| Abbvie Inc. ABBV | 2 | $31.76 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $16.44 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $15.56 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $15.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.